Trial Profile
A randomized, double-blind, parallel-group, analog classroom study, evaluating Adderall XR [SLI-381] [extended release] versus Strattera [atomoxetine], dosed once daily, in children aged 6-12 with attention deficit hyperactivity disorder (ADHD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jun 2021
Price :
$35
*
At a glance
- Drugs Mixed amfetamine salts (Primary) ; Atomoxetine
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Shire
- 18 Aug 2007 New trial record.